Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-26-000004

Chief Operating Officer gave up 42,787 shares (to pay taxes)

  • Chief Operating Officer acquired 54,166 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Donley Matthew Maxwell · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +54,166 734,631 D
2026-01-02 Shares withheld for taxes : show line 2 in the form −42,787 $15.95 $682,453 695,801 D
Loading xslF345X05/wk-form4_1767647524.xml…